rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Donald A. Wuchterl

Director

Company insider

Files Form 4 as: Director, Abeona Therapeutics.

In numbers

Trades disclosed
12
Buys
0
Sells
2
Bought
$0
Sold
$181K
Companies
1
Companies where not an officer
1
First trade
25 May 2021
Last trade
2 Feb 2026
Last filed
2 Feb 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ABEO Abeona TherapeuticsDirector · Biotechnology · last 2 Feb 20260 buys · 2 sells

Activity over time

1 Jul 2025 – 1 Oct 2026
10Jul 25Nov 25Mar 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Feb 2026filed 2 Feb 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$75K14,814 at $5.09filing
2 Feb 2026filed 2 Feb 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$75K14,814 at $5.09filing
26 Jan 2026filed 27 Jan 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—37,313 at $0.00filing
26 Jan 2026filed 27 Jan 2026ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—37,313 at $0.00filing
8 Jul 2025filed 10 Jul 2025ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$30K5,176 at $5.82filing
31 Jan 2025filed 3 Feb 2025ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—36,101 at $0.00filing
26 Aug 2024filed 27 Aug 2024ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—11,797 at $0.00filing
8 Jul 2024filed 9 Jul 2024ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—23,611 at $0.00filing
14 Jun 2023filed 16 Jun 2023ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A$271K58,689 at $4.62filing
26 Sep 2022filed 28 Sep 2022ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—13,400 at $0.00filing
25 May 2021filed 27 May 2021ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—77,181 at $0.00filing
25 May 2021filed 27 May 2021ABEO Abeona Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—98,168 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Vishwas SeshadriChief Executive Officer · Chief Executive Officer at Abeona Therapeutics, filing Form 4 there in the last year
Madhav VasanthavadaChief Commercial Officer · Chief Commercial Officer at Abeona Therapeutics, filing Form 4 there in the last year
Brendan M. O'MalleySVP, Chief Legal Officer · SVP, Chief Legal Officer at Abeona Therapeutics, filing Form 4 there in the last year
Joseph Walter VazzanoChief Financial Officer · Chief Financial Officer at Abeona Therapeutics, filing Form 4 there in the last year
Mark AlvinoDirector · Director at Abeona Therapeutics, filing Form 4 there in the last year